蘇 彥豪

Medicine & Life Sciences

1. Bariatric Surgery 100%
2. Glioma 78%
3. Gastrectomy 74%
4. Neoplasms 61%
5. Epithelial-Mesenchymal Transition 51%
6. Lung Neoplasms 49%
7. Resveratrol 46%
8. Neoplasm Metastasis 45%
9. Randomized Controlled Trials 45%
10. Meta-Analysis 44%
11. Desflurane 42%
12. GL 331 42%
13. human MIRN107 microRNA 41%
14. MicroRNAs 41%
15. Vascular Endothelial Growth Factor C 38%
16. Pancreatic Neoplasms 37%
17. 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 36%
18. Hepatocellular Carcinoma 35%
19. Apoptosis 33%
20. pterostilbene 33%
21. Gastric Bypass 33%
22. Sevoflurane 31%
23. Death-Associated Protein Kinases 31%
24. leucine-rich repeat proteins 31%
25. Blueberry Plants 30%
26. Cortactin 30%
27. Type 2 Diabetes Mellitus 30%
28. NFI Transcription Factors 29%
29. Vascular Endothelial Growth Factor Receptor-3 29%
30. Systematic Reviews 29%
31. Transcription Factor CHOP 29%
32. Topoisomerase II Inhibitors 28%
33. Confidence Intervals 28%
34. Neoplastic Stem Cells 28%
35. Growth 27%
36. CCAAT-Enhancer-Binding Proteins 27%
37. Berberine 26%
38. Cauda Equina 26%
39. HSP90 Heat-Shock Proteins 26%
40. Protein Deficiency 26%
41. Breast Neoplasms 25%
42. Celecoxib 25%
43. Fibrin Tissue Adhesive 25%
44. Gefitinib 25%
45. Tumor Microenvironment 24%
46. PC-3 Cells 24%
47. Laryngoscopy 24%
48. Cancer Vaccines 24%
49. Imipramine 24%
50. Entropy 23%